C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A61K 31/70 (2006.01) A61K 48/00 (2006.01) C07H 19/04 (2006.01) C07H 19/06 (2006.01) C07H 19/10 (2006.01) C07H 19/20 (2006.01) C07H 21/00 (2006.01) C12N 5/10 (2006.01) C12N 15/10 (2006.01) C12P 19/34 (2006.01) C12Q 1/02 (2006.01)
Patent
CA 2122365
Novel oligomers are disclosed which have enhanced ability with respect to forming duplexes or triplexes compared with oligomers containing only conventional bases. The oligomers contain the bases 5-(1- propynyl)uracil, 5-(1-propynyl)cytosine or related analogs. The oligomers of the invention are capable of (i) forming triplexes with various target sequences such as virus or oncogene sequences by coupling into the major groove of a target DNA duplex at physiological pH or (ii) forming duplexes by binding to single-stranded DNA or to RNA encoded by target genes. The oligomers of the invention can be incorporated into pharmaceutically acceptable carriers and can be constructed to have any desired sequence, provided the sequence normally includes one or more bases that is replaced with the analogs of the invention. Compositions of the invention can be used as pharmaceutical agents to treat various diseases such as those caused by viruses and can be used for diagnostic purposes in order to detect viruses or disease conditions.
Froehler Brian
Gutierrez Arnold J.
Jones Robert J.
Matteucci Mark
Pudlo Jeff
Isis Pharmaceuticals Inc.
Robic
LandOfFree
Enhanced triple-helix and double-helix formation with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced triple-helix and double-helix formation with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced triple-helix and double-helix formation with... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1556367